During the past decade, Clinique Sainte Marguerite conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Sainte Marguerite" #1 sponsor was "UNICANCER" with 10 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Sainte Marguerite" #1 collaborator was "Sanofi" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "Ferring Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Sainte Marguerite" are "Breast Cancer" (4 trials), "Colorectal Cancer" (4 trials), "Prostate Cancer" (4 trials), "Breast Neoplasms" (2 trials) and "Urinary Bladder Neoplasms" (2 trials). Many other conditions were trialed in "Clinique Sainte Marguerite" in a lesser frequency.

Most popular intervention types in "Clinique Sainte Marguerite" are "Drug" (21 trials), "Radiation" (6 trials), "Biological" (5 trials), "Other" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "docetaxel" (3 trials), "Bevacizumab" (2 trials), "Cetrelimab" (2 trials), "Docetaxel" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Sainte Marguerite" are 18 trials for "All" genders, 6 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique Sainte Marguerite". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Clinique Sainte Marguerite, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Sainte Marguerite, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".